TechNavio's analysts forecast the Global Insulin Antidiabetics Market 2012-2016 to grow at a CAGR of 12.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Insulin Antidiabetics market has also been witnessing the trend of an increase in awareness and education. However, the increase in use of complementary and alternative medicine could pose a challenge to the growth of this market.
TechNavio's report, the Global Insulin Antidiabetics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Insulin Antidiabetics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Novo Nordisk A/S, Sanofi S.A, and Eli Lilly & Co.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
01. Executive Summary
03. Market Coverage
04. Market Landscape
Market Size and Forecast
04.1 Patent Expiry Dates for Major Antidiabetics
04.2 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Novo Nordisk A/S
14.2 Sanofi S.A.
14.3 Eli Lilly & Co.
15. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Insulin Antidiabetics Market 2012â2016 (US$ billion)
Exhibit 2: Global Insulin Antidiabetics Market Segmentation
Exhibit 3: Global Insulin Antidiabetics Market Segmentation 2012
Exhibit 4: Global Insulin Antidiabetics Market by Geographical Segmentation 2012
Exhibit 5: Global Insulin Antidiabetics Market by Vendor Segmentation 2012